Hepcidin - A Novel Biomarker with Changing Trends

Pharmacognosy Reviews,2015,9,17,35-40.
Published:May 2015
Type:Review Article
Authors:
Author(s) affiliations:

Arunava Kali1, Marie Victor Pravin Charles1, Rathan Shetty Kolkebail Seetharam2

1Department of Microbiology, Mahatma Gandhi Medical College and Research Institute, Pillayarkuppam, Puducherry, India

2Department of Otorhinolaryngology, Mahatma Gandhi Medical College and Research Institute, Pillayarkuppam, Puducherry, India

Abstract:

Hepcidin is a novel peptide hormone of hepatic origin. It has a crucial role in iron metabolism. The causative association of this peptide in anemia and iron overloading states has been well established. Current research has expanded the diagnostic implications of hepcidin in other medical conditions. Increased serum hepcidin has been reported in neoplastic diseases, inflammation and sepsis. However, the clinical use of hepcidin as a biomarker is limited owing to nonavailability of an appropriate diagnostic test. Assays for serum and urine hepcidin estimation have been developed recently, which are likely to facilitate the use of hepcidin in research as well as in patient care in the near future.

Cite This Article

Vancouver Style ::
A. Kali, Charles, M. Victor Pra, and Seetharam, R. Shetty Kol, Hepcidin - A Novel Biomarker with Changing Trends, Pharmacognosy Reviews, vol. 9, no. 17, pp. 35-40, 2015.